Healthcare Stocks Surge as Investors Rotate Away From Tech
AbbVie, Eli Lilly, and J&J are hitting record highs as money pours into pharma and away from tech.
If you've been watching your tech-heavy portfolio bleed, here's where the smart money is quietly piling in: healthcare. Shares of AbbVie, Eli Lilly, and Johnson & Johnson were all tracking toward all-time highs Friday, a clear signal that the biopharma trade is back in full force.
This isn't random noise. When investors get nervous about stretched valuations in tech, they don't just go to cash — they rotate. Healthcare, and biopharma in particular, offers the combination of defensive stability and genuine growth catalysts that makes it an attractive landing spot during periods of uncertainty.
Read more BoE's Mann: Fewer Rate Hike Bets Are Why She'd Hike More →
All three names hitting records simultaneously is worth paying attention to. That's not a one-stock story — that's a sector-wide move. It suggests institutional money is making a deliberate call on biopharmaceuticals, not just chasing a headline.
For retail traders, the message is simple: follow the rotation. Tech may still have its fans, but right now the bid is in healthcare. Watch for volume confirmation and whether other large-cap pharma names start joining the party — that would tell you this move has legs beyond just Friday's session.
Continue reading at MarketWatch.com
